$1.99 Billion is the total value of Perceptive Advisors's 126 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 59.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FOLD | AMICUS THERAPEUTICS INC | $174,178,000 | +41.2% | 17,296,672 | 0.0% | 8.76% | +24.8% | |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $164,569,000 | +12.9% | 3,577,589 | +6.3% | 8.28% | -0.3% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $146,181,000 | +158.5% | 1,832,761 | +66.1% | 7.36% | +128.3% |
GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $107,592,000 | -24.3% | 3,933,927 | +1.9% | 5.41% | -33.2% |
VSAR | VERSARTIS INC | $76,907,000 | -18.3% | 4,407,317 | 0.0% | 3.87% | -27.8% | |
LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $64,214,000 | +0.6% | 2,157,011 | +0.8% | 3.23% | -11.2% |
PBYI | New | PUMA BIOTECHNOLOGY INC | $64,092,000 | – | 733,320 | +100.0% | 3.22% | – |
RTRX | Sell | RETROPHIN INC | $51,816,000 | -0.0% | 2,672,309 | -4.8% | 2.61% | -11.7% |
TSRO | Buy | TESARO INC | $50,287,000 | +35.6% | 359,551 | +49.2% | 2.53% | +19.7% |
ZGNX | Buy | ZOGENIX INC | $50,000,000 | +109.2% | 3,448,302 | +56.5% | 2.52% | +84.7% |
CORI | Buy | CORIUM INTL INC | $43,620,000 | +293.1% | 5,847,133 | +120.3% | 2.20% | +247.3% |
NXTM | Sell | NXSTAGE MEDICAL INC | $38,997,000 | -20.1% | 1,555,523 | -14.4% | 1.96% | -29.4% |
DOVA | New | DOVA PHARMACEUTICALS INC | $38,037,000 | – | 1,706,499 | +100.0% | 1.91% | – |
SRPT | Sell | SAREPTA THERAPEUTICS | $36,743,000 | -29.9% | 1,089,961 | -38.5% | 1.85% | -38.1% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $35,742,000 | +11.4% | 277,352 | -5.5% | 1.80% | -1.6% |
IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $32,068,000 | – | 4,363,114 | +100.0% | 1.61% | – |
RDUS | Sell | RADIUS HEALTH INC | $29,212,000 | -17.0% | 645,873 | -29.1% | 1.47% | -26.7% |
VBIV | VBI VACCINES IN | $28,561,000 | -20.8% | 6,565,843 | 0.0% | 1.44% | -30.0% | |
XNCR | Sell | XENCOR INC | $27,297,000 | -29.0% | 1,293,095 | -19.5% | 1.37% | -37.3% |
EVH | Sell | EVOLENT HEALTH INCcl a | $27,234,000 | -15.5% | 1,074,327 | -25.6% | 1.37% | -25.3% |
RGNX | Sell | REGENXBIO INC | $27,080,000 | +0.5% | 1,371,186 | -1.8% | 1.36% | -11.2% |
QTNT | Buy | QUOTIENT LTD | $26,010,000 | +27.7% | 3,714,486 | +27.3% | 1.31% | +12.8% |
ANAB | Buy | ANAPTYSBIO INC | $22,788,000 | -6.9% | 952,269 | +8.0% | 1.15% | -17.7% |
BPMC | Sell | BLUEPRINT MEDICINES CORP | $22,530,000 | +22.0% | 444,661 | -3.7% | 1.13% | +7.8% |
AVXS | Sell | AVEXIS INC | $22,280,000 | -34.7% | 271,181 | -39.5% | 1.12% | -42.3% |
SAGE | Buy | SAGE THERAPEUTICS INCcall | $21,901,000 | +1014.0% | 275,000 | +37.5% | 1.10% | +883.9% |
XLRN | Buy | ACCELERON PHARMA INC | $21,615,000 | +23.0% | 711,259 | +7.1% | 1.09% | +8.7% |
CTMX | Sell | CYTOMX THERAPEUTICS INC | $21,550,000 | -18.5% | 1,390,381 | -9.2% | 1.08% | -28.0% |
DBVT | DBV TECHNOLOGIES S Asponsored adr | $21,131,000 | +1.4% | 591,765 | 0.0% | 1.06% | -10.4% | |
KDMN | KADMON HLDGS INC | $20,172,000 | +7.5% | 5,185,847 | 0.0% | 1.02% | -5.1% | |
ISRG | New | INTUITIVE SURGICAL INC | $19,357,000 | – | 20,695 | +100.0% | 0.97% | – |
HUM | Buy | HUMANA INC | $18,791,000 | +231.5% | 78,093 | +184.0% | 0.95% | +192.9% |
ALBO | New | ALBIREO PHARMA INC | $17,407,000 | – | 845,000 | +100.0% | 0.88% | – |
GLPG | Sell | GALAPAGOS NVspon adr | $17,325,000 | -25.9% | 226,405 | -16.6% | 0.87% | -34.6% |
SELB | Buy | SELECTA BIOSCIENCES INC | $15,834,000 | +679.2% | 797,325 | +462.0% | 0.80% | +587.1% |
AKBA | Buy | AKEBIA THERAPEUTICS INC | $15,808,000 | +3359.1% | 1,100,000 | +2116.7% | 0.80% | +2957.7% |
AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $15,763,000 | +15.6% | 1,429,114 | +1.5% | 0.79% | +2.1% |
MYOK | Sell | MYOKARDIA INC | $14,492,000 | +76.4% | 553,154 | -11.5% | 0.73% | +55.8% |
ATRS | Buy | ANTARES PHARMA INC | $13,741,000 | +65.9% | 4,267,253 | +46.3% | 0.69% | +46.4% |
BOLD | Buy | AUDENTES THERAPEUTICS INC | $13,534,000 | +10473.4% | 707,500 | +9333.3% | 0.68% | +9628.6% |
ALDX | ALDEYRA THERAPEUTICS INC | $13,417,000 | +4.0% | 2,885,458 | 0.0% | 0.68% | -8.2% | |
AVEO | Buy | AVEO PHARMACEUTICALS INC | $13,343,000 | +342.7% | 6,010,660 | +17.7% | 0.67% | +290.1% |
JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $13,306,000 | +205.6% | 85,572 | +185.2% | 0.67% | +170.2% |
AXGT | Buy | AXOVANT SCIENCES LTD | $13,281,000 | +186.8% | 572,700 | +84.7% | 0.67% | +153.0% |
WVE | Sell | WAVE LIFE SCIENCES LTD | $12,328,000 | -32.6% | 662,798 | -0.4% | 0.62% | -40.5% |
IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $12,019,000 | +17.9% | 282,857 | +4.4% | 0.60% | +4.1% |
ZYNE | New | ZYNERBA PHARMACEUTICALS INCput | $10,164,000 | – | 100,000 | +100.0% | 0.51% | – |
ARGX | New | ARGENX SEsponsored adr | $9,544,000 | – | 450,000 | +100.0% | 0.48% | – |
ARDX | Sell | ARDELYX INC | $9,233,000 | -61.3% | 1,810,581 | -4.0% | 0.46% | -65.8% |
ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $9,124,000 | -46.1% | 441,833 | -33.5% | 0.46% | -52.4% |
RDUS | Buy | RADIUS HEALTH INCput | $9,046,000 | +1487.0% | 200,000 | +1940.8% | 0.46% | +1321.9% |
CSU | Sell | CAPITAL SR LIVING CORP | $8,064,000 | -0.3% | 530,173 | -7.8% | 0.41% | -11.9% |
ACRX | Sell | ACELRX PHARMACEUTICALS INC | $8,022,000 | -52.9% | 3,731,342 | -31.0% | 0.40% | -58.4% |
ANI PHARMACEUTICALS INCnote 3.000%12/0 | $7,908,000 | -0.6% | 7,500,000 | 0.0% | 0.40% | -12.1% | ||
EGRX | New | EAGLE PHARMACEUTICALS INC | $7,889,000 | – | 100,000 | +100.0% | 0.40% | – |
CRBP | Sell | CORBUS PHARMACEUTICALS HLDGS | $7,764,000 | -24.7% | 1,232,500 | -1.4% | 0.39% | -33.4% |
AXGT | Buy | AXOVANT SCIENCES LTDcall | $6,957,000 | +389.9% | 300,000 | +50.0% | 0.35% | +332.1% |
QURE | Sell | UNIQURE NV | $6,748,000 | -7.8% | 1,090,119 | -13.9% | 0.34% | -18.5% |
VIVE | Sell | VIVEVE MED INC | $6,394,000 | +7.6% | 890,468 | -5.1% | 0.32% | -4.7% |
RARE | New | ULTRAGENYX PHARMACEUTICAL INcall | $6,211,000 | – | 100,000 | +100.0% | 0.31% | – |
NVTA | Buy | INVITAE CORP | $6,209,000 | +17.0% | 649,500 | +35.3% | 0.31% | +3.3% |
ZYME | New | ZYMEWORKS INC | $6,101,000 | – | 730,768 | +100.0% | 0.31% | – |
ANIP | Sell | ANI PHARMACEUTICALS INC | $5,869,000 | -53.5% | 125,399 | -50.8% | 0.30% | -59.0% |
CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $5,649,000 | -0.1% | 620,181 | -12.9% | 0.28% | -11.8% |
UNH | Buy | UNITEDHEALTH GROUP INC | $5,281,000 | +147.7% | 28,480 | +119.1% | 0.27% | +119.8% |
FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $5,184,000 | -20.8% | 1,117,324 | -15.5% | 0.26% | -30.0% |
URGN | New | UROGEN PHARMA LTD | $4,858,000 | – | 269,014 | +100.0% | 0.24% | – |
ABEOW | ABEONA THERAPEUTICS INC*w exp 12/24/201 | $4,285,000 | +16.1% | 1,259,636 | 0.0% | 0.22% | +2.9% | |
SRRA | Sell | SIERRA ONCOLOGY INC | $4,277,000 | -24.5% | 3,655,186 | -1.3% | 0.22% | -33.4% |
FWP | Sell | FORWARD PHARMA A/Ssponsored adr | $3,959,000 | -48.1% | 194,718 | -45.0% | 0.20% | -54.3% |
NEPT | NEPTUNE TECHNOLOGIES BIORESO | $3,801,000 | -17.5% | 6,519,634 | 0.0% | 0.19% | -27.4% | |
EXAS | Sell | EXACT SCIENCES CORP | $3,537,000 | -63.5% | 100,000 | -75.6% | 0.18% | -67.8% |
PFNX | Sell | PFENEX INC | $3,392,000 | -34.6% | 845,973 | -5.2% | 0.17% | -42.0% |
HSGX | HISTOGENICS CORP | $3,182,000 | +3.5% | 1,777,777 | 0.0% | 0.16% | -8.6% | |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $3,000,000 | – | 120,000 | +100.0% | 0.15% | – |
ADMA | ADMA BIOLOGICS INC | $2,769,000 | -21.3% | 721,102 | 0.0% | 0.14% | -30.5% | |
ABEO | Sell | ABEONA THERAPEUTICS INC | $2,706,000 | -13.1% | 422,873 | -32.1% | 0.14% | -23.2% |
OCRX | Sell | OCERA THERAPEUTICS INC | $2,365,000 | -16.0% | 2,038,880 | -5.2% | 0.12% | -25.6% |
VRNA | New | VERONA PHARMA PLCsponsored ads | $2,331,000 | – | 200,000 | +100.0% | 0.12% | – |
XENE | XENON PHARMACEUTICALS INC | $2,280,000 | -21.2% | 723,853 | 0.0% | 0.12% | -30.3% | |
MGCD | Sell | MGC DIAGNOSTICS CORP | $2,140,000 | -15.2% | 252,327 | -16.5% | 0.11% | -25.0% |
BLUE | Buy | BLUEBIRD BIO INC | $2,101,000 | +397.9% | 20,000 | +330.7% | 0.11% | +341.7% |
ADMP | New | ADAMIS PHARMACEUTICALS CORP | $2,080,000 | – | 400,000 | +100.0% | 0.10% | – |
PSDV | Sell | PSIVIDA CORP | $1,966,000 | -49.9% | 1,149,556 | -49.6% | 0.10% | -55.6% |
CRIS | Buy | CURIS INC | $1,798,000 | +29.4% | 951,201 | +90.2% | 0.09% | +13.9% |
BCLI | New | BRAINSTORM CELL THERAPEUTICS | $1,660,000 | – | 400,000 | +100.0% | 0.08% | – |
ALQA | ALLIQUA BIOMEDICAL INC | $1,566,000 | -26.7% | 4,233,951 | 0.0% | 0.08% | -35.2% | |
CARA | New | CARA THERAPEUTICS INCcall | $1,539,000 | – | 100,000 | +100.0% | 0.08% | – |
ARWR | ARROWHEAD PHARMACEUTICALS IN | $1,372,000 | -12.4% | 847,458 | 0.0% | 0.07% | -22.5% | |
AFMD | Sell | AFFIMED N V | $1,369,000 | -18.9% | 668,214 | -9.0% | 0.07% | -28.1% |
EIGR | EIGER BIOPHARMACEUTICALS INC | $1,245,000 | -31.0% | 157,679 | 0.0% | 0.06% | -38.8% | |
EXEL | EXELIXIS SHARES | $1,142,000 | +13.6% | 46,361 | 0.0% | 0.06% | 0.0% | |
LNTH | LANTHEUS HLDGS INC | $949,000 | +41.2% | 53,763 | 0.0% | 0.05% | +26.3% | |
OSUR | Buy | ORASURE TECHNOLOGIES INC | $945,000 | +55.2% | 54,729 | +16.1% | 0.05% | +37.1% |
CSBR | Buy | CHAMPIONS ONCOLOGY INC | $943,000 | -18.9% | 366,973 | +0.0% | 0.05% | -28.8% |
AZRX | AZURRX BIOPHARMA INC | $916,000 | +4.4% | 227,272 | 0.0% | 0.05% | -8.0% | |
WCG | Sell | WELLCARE HEALTH PLANS INC | $908,000 | +22.5% | 5,056 | -4.3% | 0.05% | +9.5% |
ONS | Sell | ONCOBIOLOGICS INC | $837,000 | -73.6% | 837,886 | -29.1% | 0.04% | -76.7% |
OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $741,000 | – | 44,106 | +100.0% | 0.04% | – |
LHCG | Buy | LHC GROUP INC | $728,000 | +184.4% | 10,730 | +126.1% | 0.04% | +146.7% |
HSKA | Buy | HESKA CORP | $745,000 | +12.7% | 7,300 | +15.9% | 0.04% | -2.6% |
INCY | INCYTE CORP | $707,000 | -5.9% | 5,619 | 0.0% | 0.04% | -16.3% | |
EW | New | EDWARDS LIFESCIENCES CORP | $719,000 | – | 6,088 | +100.0% | 0.04% | – |
ZSAN | ZOSANO PHARMA CORP | $705,000 | -25.8% | 500,000 | 0.0% | 0.04% | -35.2% | |
FCAU | FIAT CHRYSLER AUTOMOBILES N | $659,000 | -2.8% | 62,000 | 0.0% | 0.03% | -15.4% | |
HRC | HILL ROM HLDGS INC | $631,000 | +12.7% | 7,930 | 0.0% | 0.03% | 0.0% | |
ACOR | New | ACORDA THERAPEUTICS INC | $626,000 | – | 31,786 | +100.0% | 0.03% | – |
CNC | CENTENE CORP DEL | $617,000 | +12.0% | 7,726 | 0.0% | 0.03% | 0.0% | |
AKAOQ | Buy | ACHAOGEN INC | $599,000 | +1.0% | 27,551 | +17.3% | 0.03% | -11.8% |
VNDA | VANDA PHARMACEUTICALS INC | $591,000 | +16.6% | 36,232 | 0.0% | 0.03% | +3.4% | |
MOH | New | MOLINA HEALTHCARE INC | $563,000 | – | 8,140 | +100.0% | 0.03% | – |
RACE | FERRARI N V | $533,000 | +15.6% | 6,200 | 0.0% | 0.03% | +3.8% | |
PRTO | PROTEON THERAPEUTICS INC | $518,000 | -11.5% | 334,116 | 0.0% | 0.03% | -21.2% | |
ICLR | New | ICON PLC | $507,000 | – | 5,187 | +100.0% | 0.03% | – |
INCR | New | INC RESH HLDGS INCcl a | $499,000 | – | 8,532 | +100.0% | 0.02% | – |
CDTX | Sell | CIDARA THERAPEUTICS INC | $465,000 | -92.8% | 62,110 | -92.5% | 0.02% | -93.7% |
DPLO | New | DIPLOMAT PHARMACY INC | $454,000 | – | 30,658 | +100.0% | 0.02% | – |
PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $442,000 | -80.5% | 7,870 | -86.4% | 0.02% | -82.9% |
VYGR | New | VOYAGER THERAPEUTICS INC | $310,000 | – | 34,604 | +100.0% | 0.02% | – |
CUTR | Sell | CUTERA INC | $310,000 | -37.5% | 11,981 | -50.0% | 0.02% | -42.9% |
New | PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $282,000 | – | 1,000,000 | +100.0% | 0.01% | – | |
ACST | ACASTI PHARMA INC | $247,000 | -2.8% | 186,559 | 0.0% | 0.01% | -14.3% | |
ARNI | ARNO THERAPEUTICS INC | $208,000 | -18.1% | 4,177,577 | 0.0% | 0.01% | -28.6% | |
ONSIW | ONCOBIOLOGICS INCw exp 02/18/201 | $80,000 | -78.4% | 462,500 | 0.0% | 0.00% | -81.0% | |
ONSIZ | ONCOBIOLOGICS INC*w exp 05/18/201 | $42,000 | -81.8% | 462,500 | 0.0% | 0.00% | -84.6% | |
PPHM | PEREGRINE PHARMACEUTICALS IN | $15,000 | -6.2% | 24,332 | 0.0% | 0.00% | 0.0% | |
IWS | Exit | ISHARES RUSSELL MID-CAP VALUE ETF | $0 | – | -2 | -100.0% | 0.00% | – |
ACHC | Exit | ACADIA HEALTHCARE COMPANY SHARES | $0 | – | -1 | -100.0% | 0.00% | – |
TCON | Exit | TRACON PHARMACEUTICALS SHARES | $0 | – | -50 | -100.0% | 0.00% | – |
TLT | Exit | ISHARES 20 PLUS YEAR TREASURY BOND ETFnote | $0 | – | -2 | -100.0% | 0.00% | – |
XIV | Exit | CREDIT SUISSE VELOCITYSHARES DAILY INVERSE VIX SHORT TERM ET | $0 | – | -16 | -100.0% | 0.00% | – |
ATRC | Exit | ATRICURE SHARES | $0 | – | -55 | -100.0% | 0.00% | – |
AGRX | Exit | AGILE THERAPEUTICS SHARES | $0 | – | -42 | -100.0% | 0.00% | – |
IVV | Exit | ISHARES CORE SandP 500 ETF | $0 | – | -1 | -100.0% | 0.00% | – |
BSX | Exit | BOSTON SCIENTIFIC SHARES | $0 | – | -3 | -100.0% | 0.00% | – |
CASC | Exit | CASCADIAN THERAPEUTICS SHARES | $0 | – | -1,966 | -100.0% | 0.00% | – |
DHR | Exit | DANAHER SHARES | $0 | – | -3 | -100.0% | 0.00% | – |
GNMX | Exit | AEVI GENOMIC MEDICINE SHARES | $0 | – | -940 | -100.0% | 0.00% | – |
APVO | Exit | APTEVO THERAPEUTICS SHARES | $0 | – | -450 | -100.0% | 0.00% | – |
CRY | Exit | CRYOLIFE SHARES | $0 | – | -123 | -100.0% | 0.00% | – |
FPRX | Exit | FIVE PRIME THERAPEUTICS SHARES | $0 | – | -127 | -100.0% | 0.00% | – |
OPHT | Exit | OPHTHOTECH SHARES | $0 | – | -1,600 | -100.0% | 0.00% | – |
NPCUF | Exit | ALLON THERAPEUTICS SHARES | $0 | – | -751,124 | -100.0% | 0.00% | – |
TNGNQ | Exit | TENGION INC | $0 | – | -1,826,399 | -100.0% | 0.00% | – |
CERS | Exit | CERUS SHARES | $0 | – | -740 | -100.0% | 0.00% | – |
TXMD | Exit | THERAPEUTICSMD SHARES | $0 | – | -1,081 | -100.0% | 0.00% | – |
OBLN | Exit | OBALON THERAPEUTICS SHARES | $0 | – | -4 | -100.0% | 0.00% | – |
WST | Exit | WEST PHARMACEUTICAL SERVICES SHARES | $0 | – | -138 | -100.0% | -0.00% | – |
CBPO | Exit | CHINA BIOLOGIC PRODUCTS SHARES | $0 | – | -236 | -100.0% | -0.00% | – |
CLDX | Exit | CELLDEX THERAPEUTICS SHARES | $0 | – | -6,970 | -100.0% | -0.00% | – |
Exit | SEVION THERAPEUTICS INC | $0 | – | -59,220 | -100.0% | -0.00% | – | |
AGEN | Exit | AGENUS SHARES | $0 | – | -3,600 | -100.0% | -0.00% | – |
CAPR | Exit | CAPRICOR THERAPEUTICS SHARES | $0 | – | -4,000 | -100.0% | -0.00% | – |
ABBV | Exit | ABBVIE SHARES | $0 | – | -380 | -100.0% | -0.00% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL SHARES | $0 | – | -250 | -100.0% | -0.00% | – |
ABT | Exit | ABBOTT LABORATORIES SHARES | $0 | – | -415 | -100.0% | -0.00% | – |
EPZM | Exit | EPIZYME SHARES | $0 | – | -1,165 | -100.0% | -0.00% | – |
ADHD | Exit | ALCOBRA SHARES | $0 | – | -9,109 | -100.0% | -0.00% | – |
AGLE | Exit | AEGLEA BIOTHERAPEUTICS SHARES | $0 | – | -5,833 | -100.0% | -0.00% | – |
RCM | Exit | R1 RCM SHARES | $0 | – | -17,976 | -100.0% | -0.00% | – |
RXDX | Exit | IGNYTA SHARES | $0 | – | -6,584 | -100.0% | -0.00% | – |
EVH | Exit | EVOLENT HEALTH INC SHARES -A- CALL 20 06/16/2017call | $0 | – | -50,000 | -100.0% | -0.01% | – |
ARRY | Exit | ARRAY BIOPHARMA SHARES | $0 | – | -25,510 | -100.0% | -0.01% | – |
Exit | PERNIX THERAPEUTICS HOLD 01APR21 4.25PCT | $0 | – | -1,000,000 | -100.0% | -0.02% | – | |
QHCCQ | Exit | QUORUM HEALTH SHARES | $0 | – | -50,604 | -100.0% | -0.02% | – |
EARS | Exit | AURIS MEDICAL HOLDING SHARES | $0 | – | -400,000 | -100.0% | -0.02% | – |
ANTM | Exit | ANTHEM SHARES | $0 | – | -3,081 | -100.0% | -0.03% | – |
PAHC | Exit | PHIBRO ANIMAL HEALTH SHARES CLASS A | $0 | – | -18,382 | -100.0% | -0.03% | – |
QSII | Exit | QUALITY SYSTEMS SHARES | $0 | – | -33,875 | -100.0% | -0.03% | – |
MCK | Exit | MCKESSON SHARES | $0 | – | -3,601 | -100.0% | -0.03% | – |
CBM | Exit | CAMBREX SHARES | $0 | – | -9,515 | -100.0% | -0.03% | – |
HMSY | Exit | HMS HOLDINGS SHARES | $0 | – | -26,553 | -100.0% | -0.03% | – |
MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTIONS SHARES | $0 | – | -42,955 | -100.0% | -0.03% | – |
PRAH | Exit | PRA HEALTH SCIENCES SHARES | $0 | – | -8,308 | -100.0% | -0.03% | – |
MASI | Exit | MASIMO SHARES | $0 | – | -5,945 | -100.0% | -0.03% | – |
ILMN | Exit | ILLUMINA SHARES | $0 | – | -3,500 | -100.0% | -0.03% | – |
MTST | Exit | METASTAT SHARES | $0 | – | -500,000 | -100.0% | -0.04% | – |
AKRXQ | Exit | AKORN SHARES | $0 | – | -40,000 | -100.0% | -0.06% | – |
BLCM | Exit | BELLICUM PHARMACEUTICALS SHARES | $0 | – | -86,200 | -100.0% | -0.06% | – |
BCLI | Exit | BRAINSTORM CELL THERAPEUTICS INC SHARES (OLD) | $0 | – | -400,000 | -100.0% | -0.10% | – |
IMMU | Exit | IMMUNOMEDICS SHARES | $0 | – | -300,060 | -100.0% | -0.11% | – |
RARX | Exit | RA PHARMACEUTICALS SHARES | $0 | – | -100,000 | -100.0% | -0.12% | – |
AERI | Exit | AERIE PHARMACEUTICALS SHARES | $0 | – | -50,000 | -100.0% | -0.13% | – |
AMGN | Exit | AMGEN SHARES | $0 | – | -20,000 | -100.0% | -0.19% | – |
DERM | Exit | DERMIRA SHARES | $0 | – | -115,583 | -100.0% | -0.22% | – |
PPHMP | Exit | PEREGRINE PHARMACEUTICALS INC 10.5 | $0 | – | -200,000 | -100.0% | -0.25% | – |
SGYPQ | Exit | SYNERGY PHARMACEUTICALS SHARES | $0 | – | -978,100 | -100.0% | -0.26% | – |
ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -251,328 | -100.0% | -0.29% | – |
NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -810,537 | -100.0% | -0.37% | – |
ALDR | Exit | ALDER BIOPHARMACEUTICALS SHARES | $0 | – | -384,169 | -100.0% | -0.46% | – |
BIO | Exit | BIO RAD LABORATORIES SHARES CLASS A | $0 | – | -49,416 | -100.0% | -0.56% | – |
CLVS | Exit | CLOVIS ONCOLOGY SHARES | $0 | – | -157,754 | -100.0% | -0.57% | – |
ABMD | Exit | ABIOMED SHARES | $0 | – | -85,000 | -100.0% | -0.61% | – |
AMAG | Exit | AMAG PHARMACEUTICALS SHARES | $0 | – | -560,000 | -100.0% | -0.72% | – |
NVRO | Exit | NEVRO SHARES | $0 | – | -217,292 | -100.0% | -1.16% | – |
LBIO | Exit | LION BIOTECHNOLOGIES SHARES | $0 | – | -3,567,553 | -100.0% | -1.51% | – |
ACRS | Exit | ACLARIS THERAPEUTICS SHARES | $0 | – | -1,260,847 | -100.0% | -2.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-03-20 |
SC 13G | 2024-03-14 |
SC 13G | 2024-03-11 |
SC 13G/A | 2024-03-06 |
SC 13D/A | 2024-03-01 |
SC 13G | 2024-03-01 |
SC 13D/A | 2024-02-29 |
13F-HR/A | 2024-02-26 |
SC 13G/A | 2024-02-23 |
4 | 2024-02-21 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.